ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,981, issued on July 15, was assigned to ALAMAB THERAPEUTICS INC. (Princeton, N.J.).
"Anti-connexin antibody formulations" was invented by Yanfeng Zhang (Princeton, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to pharmaceutical compositions and methods for treating a disease or condition associated with insufficient opening of Cx43 hemichannels in osteocytes, optionally for treating cancer, cancer metastasis, osteosarcoma, osteoporosis, or osteopenia."
The patent was filed on Oct. 2, 2020, under Application No. 17/061,918.
*For further information, including images, charts and tables, please visit: http://patft...